Skip to main content
Media RelationsInvestor RelationsHome
Logo SphingotecLogo Sphingotec
Request a Quote

The Biomarker Company

SphingoTec develops and markets innovative in vitro diagnostics solutions for novel and proprietary blood-based protein biomarkers. Our aspiration is to effectively translate scientific advancements into routine clinical practice.

Our innovative biomarkers address diagnostically underserved critical care conditions such as sepsis, acute heart failure, acute kidney injury, and cardiogenic shock. 
We are a fully integrated diagnostics company: our innovative biomarkers are commercially available on the point of care platform Nexus IB10. The assay portfolio for near patient testing goes beyond innovation: on the Nexus IB10 platform, clinicians can deploy a wide range of commonly used parameters in acute and critical care settings, making the analyzer a useful addition to intensive care units (ICU), emergency departments (ED), and other near patient settings. 

Integrated diagnostic solutions for unmet medical needs

Rapid Testing

Point of care diagnostics

Nexus IB10 is a point of care analyzer that provides rapid and reliable diagnostic results. Fully automatic and compact, Nexus IB10 is a solution for near patient testing in acute and critical care settings. 

Read more

Test portfolio

Biomarker-based diagnostics

The Nexus IB10 test portfolio includes biomarker innovations and established parameters for acute and critical care such as PCT, Troponin, NT-proBNP, D-dimer, TSH, and others. 

Read more

From bench to bedside

Biomarker innovations

The main mortality drivers in intensive care units are diagnostic blind spots. We pave the way for early intervention and personalized medicine in critical care with innovative biomarkers.

 

Read more

Latest News

View all News

26. August 2022

Interdepartmental testing of the kidney function biomarker penKid in routine care at Heidelberg University Hospital and the Heidelberg Kidney Center

Four units at the University Hospital Heidelberg and Heidelberg Kidney Center implement Proenkephalin (penKid) in a pilot biomarker-based treatment approach to diagnose AKI faster and monitor it more accurately across departments.
Read more
08. August 2022

Medical thought leaders in critical care aim to advance precision medicine using biomarker-based approaches

International medical experts discussed the latest developments in diagnostic and therapeutic innovations for advancing precision medicine in critically ill patients during the 4th Scientific Symposium.
Read more
01. August 2022

Endothelial function biomarker bioactive Adrenomedullin (bio-ADM) enables triage of sepsis patients in the emergency department

New findings support the clinical value of the biomarker bio-ADM for triaging sepsis patients in ED, exceeding the prognostic performance of routine biomarkers. So far, the predictive potential of the innovative biomarker has been confirmed and used primarily in ICU. A new study, recently published, confirms its applicability in ED.
Read more

Events & Expos

View all Events

21. - 24. March 2023

08:05 - 10:07

Brussels, Belgium

42nd International Symposium on Intensive Care and Emergency Medicine (ISICEM)

The International Symposium on Intensive Care and Emergency Medicine is organized by the Departments of Intensive Care and Emergency Medicine of Erasme University Hospital, Université Libre de…

Read more
15. - 17. February 2023

08:02 - 10:03

Bremen, Germany

33. Symposium Intensivmedizin + Intensivpflege

The Symposium Intensivmedizin + Intensivpflege in Bremen is the largest annual meeting of intensive care physicians and nurses, administrative experts, and industry representatives independent of…

Read more
30. November - 02. December 2022

13:08 - 15:10

Hamburg, Germany

22. Kongress der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin (DIVI)

The DIVI is the largest event for emergency and intensive care medicine in German-speaking countries. We look forward to once again be exhibiting.
Read more

Subscribe to our Newsletter

Follow the link below to subscribe to our Newsletter & receive updates on our company and products

Subscribe now

Follow our Journey on Social Media